GGrantIndex
← Leaderboards

Charles Wayne Frevert

University Of Washington

$6,064,602
Attributed
$9,520,061
Total exposure
8
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY201023
$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$9,520,061 · 8

By mechanism

R01$6,910,918 · 2
P01$1,262,959 · 1
P30$949,804 · 3
R21$388,380 · 1
R13$8,000 · 1

Top collaborators

Most similar at University Of Washington

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsBaseMouse ModelLungImmune ResponseLeukocytesTissuesExtracellular MatrixInflammatoryMacrophageFibroblastsInflammationInfectionGlycosaminoglycansMigrationPhenotypeIn VitroResearch PersonnelChemokineResponseGenesLiquid SubstancePublishingBacteria

Grant awards (24)

Regulation of Allergen-Induced Airway Pathophysiology by Versican$762,723
R01 · FY2023 · AI · contact PI
Regulation of Allergen-Induced Airway Pathophysiology by Versican$762,723
R01 · FY2022 · AI · contact PI
Impact of versican deficiency on the innate immune response to influenza virus$616,343
R01 · FY2022 · AI · contact PI
2022 Proteoglycans Gordon Research Conference and Gordon Research Seminar$8,000
R13 · FY2022 · AR · contact PI
Regulation of Allergen-Induced Airway Pathophysiology by Versican$762,723
R01 · FY2021 · AI · contact PI
Impact of versican deficiency on the innate immune response to influenza virus$616,343
R01 · FY2021 · AI · contact PI
Regulation of Allergen-Induced Airway Pathophysiology by Versican$762,723
R01 · FY2020 · AI · contact PI
Impact of versican deficiency on the innate immune response to influenza virus$616,343
R01 · FY2020 · AI · contact PI
Regulation of Allergen-Induced Airway Pathophysiology by Versican$781,075
R01 · FY2019 · AI · contact PI
Impact of versican deficiency on the innate immune response to influenza virus$615,325
R01 · FY2019 · AI · contact PI
Host Response Core$167,246
P30 · FY2019 · DK · contact PI
Impact of versican deficiency on the innate immune response to influenza virus$614,597
R01 · FY2018 · AI · contact PI
Host Response Core$168,780
P30 · FY2016 · DK · contact PI
Host Response Core$168,780
P30 · FY2015 · DK · contact PI
Core B: Cellular And Molecular Imaging Core$152,648
P30 · FY2015 · DK · contact PI
Mouse Models of Pulmonary Inflammation Core$278,614
P01 · FY2014 · HL · contact PI
Core B: Cellular And Molecular Imaging Core$152,748
P30 · FY2014 · DK · contact PI
Mouse Models of Pulmonary Inflammation Core$271,275
P01 · FY2013 · HL · contact PI
Core B: Cellular And Molecular Imaging Core$139,602
P30 · FY2013 · DK · contact PI
Mouse Models of Pulmonary Inflammation Core$246,748
P01 · FY2012 · HL · contact PI
Mouse Models of Pulmonary Inflammation Core$225,113
P01 · FY2011 · HL · contact PI
Gene-targeted mouse models to study the function of versican$209,920
R21 · FY2011 · RR · contact PI
Mouse Models of Pulmonary Inflammation Core$241,209
P01 · FY2010 · HL · contact PI
Gene-targeted mouse models to study the function of versican$178,460
R21 · FY2010 · RR · contact PI